Strides Pharma Inc.
Strides Pharma Inc., the US subsidiary of India-based Strides Pharma Science Limited, develops and manufactures generic pharmaceuticals in soft-gel capsules, oral solids, modified releases, topicals, and liquids for sale to US healthcare providers, pharmacies, and distributors.
- Company typePrivate
- Founded-
- HeadquartersBridgewater, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Strides Pharma Inc. does
Strides Pharma Inc. is the US-based commercial and manufacturing subsidiary of India-headquartered Strides Pharma Science Limited, operating from 200 Crossing Boulevard, Suite 110 in Bridgewater, NJ (commercial) and 1 Ram Ridge Road in Chestnut Ridge, NY (manufacturing), with the parent's innovative R&D hub in Bangalore feeding the pipeline. The company specializes in generic pharmaceutical products across multiple dosage forms: soft-gel capsules (SGC), oral solids, modified releases, topicals, and liquids, and operates cGMP-compliant facilities including a chestnut ridge site cleared by USFDA under Voluntary Action Indicated (VAI) classification following its December 2025 inspection. Its 14-product US portfolio spans cardiovascular (Amlodipine/Valsartan/HCTZ), respiratory (Benzonatate), mental health (Buspirone HCl, Doxepin HCl), endocrine/metabolic (Calcitriol, Methimazole, Megestrol Acetate, Testosterone Gel), anti-inflammatory/immunosuppressant (Hydrocortisone, Mycophenolate Mofetil, Children's Ibuprofen), and gastrointestinal (Omeprazole/Sodium Bicarbonate, PEG bowel preparations) categories, with Wholesale Acquisition Cost pricing disclosed by strength and pack size.
Revenue is generated through B2B direct sales to US healthcare providers, pharmacies, pharmacy chains, and pharmaceutical distributors, with tiered unit pricing, minimum order quantities on certain SKUs, and contract manufacturing relationships (e.g., Taro Pharmaceuticals USA for Children's Ibuprofen Oral Suspension). The go-to-market is sales-led and the customer model is horizontal across the US generics market. Product breadth is supported by the parent's integrated value chain — from formulation R&D through commercial launch — and recently expanded by drug-device combination nasal spray capabilities cleared in pre-approval inspection.
Strides Pharma Inc. firmographics
Firmographics- Name
- Strides Pharma Inc.
- Legal name
- Strides Pharma Inc.
- Website
- https://stridespharmausa.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Strides Pharma Inc., the US subsidiary of India-based Strides Pharma Science Limited, develops and manufactures generic pharmaceuticals in soft-gel capsules, oral solids, modified releases, topicals, and liquids for sale to US healthcare providers, pharmacies, and distributors.
- Ownership category
- akta.pro rank
Strides Pharma Inc. industry classification
Industry- Product category
- Generic Pharmaceuticals Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Strides Pharma Inc. is headquartered
LocationHeadquarters
- HQ city
- Bridgewater
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Strides Pharma Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Generic Pharmaceutical Products: Strides Pharma generates revenue through the manufacture and sale of generic pharmaceutical products including soft-gel capsules, oral solids, modified releases, topicals, and liquids. Revenue is derived from one-time product transactions to B2B customers (healthcare providers, pharmacies, distributors).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Benzonatate Capsules 100mg - WAC $29.95 (100ct), $115.00 (500ct) |
| Unit Pricing | Pay-as-you-go | Benzonatate Capsules 200mg - WAC $42.50 (100ct), $158.48 (500ct) |
| Unit Pricing | Pay-as-you-go | Calcitriol Capsules 0.25mcg - WAC $28.81 (30ct), $94.59 (100ct) |
| Unit Pricing | Pay-as-you-go | Buspirone HCl Tablets 5mg - WAC $4.80 (100ct), $24.26 (500ct), $31.97 (1000ct) |
| Unit Pricing | Pay-as-you-go | Amlodipine/Valsartan/HCTZ Tablets - WAC $239.29 to $344.60 (30ct) |
| Unit Pricing | Pay-as-you-go | Testosterone Gel - WAC $180.00 (25mg/2.5G 30ct), $190.00 (50mg/5G 30ct) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Strides Pharma Inc. product offering
Product offeringCore offering
Strides Pharma Inc. develops, manufactures, and supplies generic pharmaceutical products across multiple dosage forms including soft-gel capsules (SGC), oral solids, modified releases, topicals, and liquids. Operating as the US-based front-end of Strides Pharma Science Limited, the company sells cGMP-compliant generic medications to healthcare providers, pharmacies, and distributors in the US Rx market.
Product overview
Strides Pharma Inc. is the US-based pharmaceutical business of Strides Pharma Science Limited, specializing in generic pharmaceutical products. The company focuses on soft-gel capsules (SGC), oral solids, modified releases, topicals, liquids, and high-competition products with integrated value chain benefits. Their product portfolio includes 14 distinct pharmaceutical products across multiple therapeutic categories: cardiovascular medications (Amlodipine/Valsartan/HCTZ, Testosterone Gel), respiratory (Benzonatate Capsules), mental health (Buspirone HCl Tablets, Doxepin Hydrochloride Tablets), endocrine/metabolic (Calcitriol Capsules, Methimazole Tablets, Megestrol Acetate OS), anti-inflammatory (Hydrocortisone Tablets, Children's Ibuprofen Oral Suspension), immunosuppressant (Mycophenolate Mofetil Tablets), gastrointestinal (Omeprazole & Sodium Bicarbonate, PEG solutions), and OTC consumer health products.
Differentiator
Problem solved
Functional benefit
Products and services
- Amlodipine/Valsartan/Hydrochlorothiazide Tablets
- Benzonatate Capsules
- Buspirone HCl Tablets
- Calcitriol Capsules
- Doxepin Hydrochloride Tablets
- Hydrocortisone Tablets
- Megestrol Acetate Oral Suspension
- Methimazole Tablets
- Mycophenolate Mofetil Tablets
- Omeprazole & Sodium Bicarbonate for Oral Suspension
- PEG (GoLyTELY)
- PEG (Nulytely)
- Testosterone Gel
- Children's Ibuprofen Oral Suspension
Quantifiable outcome
- FDA inspection closed with Voluntary Action Indicated (VAI) classification, strengthening US business and near-term growth prospects
Companies that use Strides Pharma Inc.
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Strides Pharma Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Strides Pharma Inc. partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
Strides Pharma Inc. competitors and assessment
Company assessmentDirect peers
- Dr. Reddy's Laboratories: India-headquartered multinational with significant US generics operations including specialty formulations; comparable on parent-subsidiary US structure, integrated R&D-to-commercial value chain, and broad generic therapeutic portfolio.
- Taro Pharmaceutical Industries: Israel-based global generic pharmaceutical manufacturer with major US operations; directly comparable as a US-focused generic manufacturer across dosage forms including soft-gels, and a named customer relationship partner of Strides.
- Amneal Pharmaceuticals: US-based vertically integrated generic and specialty pharmaceutical manufacturer; comparable on dosage-form breadth (oral solids, injectables, topicals) and US-centric B2B distribution model.
- Apotex Corp. Canadian-headquartered generic pharmaceutical manufacturer with significant US operations; comparable on dosage-form breadth (oral solids, liquids, topicals) and FDA-regulated B2B supply to US pharmacies.
- Glenmark Pharmaceuticals: India-headquartered global generics manufacturer with US commercial operations; comparable on integrated value chain, India R&D, and broad US generic product portfolio across multiple therapeutic categories.
- Zydus Pharmaceuticals (USA): US subsidiary of India's Cadila/Zydus group; comparable as an Indian-parented US generics manufacturer across dosage forms including injectables and specialty products targeting the same pharmacy and institutional buyers.
- Aurobindo Pharma USA: US arm of India-headquartered Aurobindo Pharma; comparable as an Indian-parented US generic manufacturer offering oral solids, injectables, and specialty dosage forms across the same buyer base as Strides.
- Lupin Pharmaceuticals: Indian generic manufacturer with substantial US commercial and manufacturing footprint; directly comparable on product categories (oral solids, specialty), India R&D backbone, and US B2B distribution model.
Broad incumbents
- Hikma Pharmaceuticals: MNC generic and specialty pharmaceutical manufacturer with US operations across oral solids, injectables, and specialty dosage forms; broader incumbent offering overlapping generic categories and institutional distribution comparable to Strides' offering.
- Endo International (Par Pharmaceutical): US specialty/generic pharmaceutical manufacturer (parent of Par Pharmaceutical); comparable on US-market generics portfolio, focus on complex generics including modified-release formulations, and B2B distribution to pharmacies.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Strides Pharma Inc. social profiles
Digital presenceStrides Pharma Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Strides Pharma Inc. leadership team
Management profileNumber of profiles
Strides Pharma Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Strides Pharma Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Strides Pharma Inc.
What does Strides Pharma Inc. do?
Strides Pharma Inc. develops, manufactures, and supplies generic pharmaceutical products across multiple dosage forms including soft-gel capsules (SGC), oral solids, modified releases, topicals, and liquids. Operating as the US-based front-end of Strides Pharma Science Limited, the company sells cGMP-compliant generic medications to healthcare providers, pharmacies, and distributors in the US Rx market.
Is Strides Pharma Inc. a public or private company?
Strides Pharma Inc. is a private company. It is classified as corporate owned and is currently operating.
When was Strides Pharma Inc. founded?
Strides Pharma Inc. was founded in -1. It employs 501 to 1,000 people.
Where is Strides Pharma Inc. based?
Strides Pharma Inc. is headquartered in Bridgewater, United States, in the North America region.
How does Strides Pharma Inc. make money?
One revenue line is on record: generic Pharmaceutical Products.
Who are Strides Pharma Inc.'s main competitors?
Direct peers on record are Dr. Reddy's Laboratories, Taro Pharmaceutical Industries, Amneal Pharmaceuticals, Apotex Corp., Glenmark Pharmaceuticals, Zydus Pharmaceuticals (USA), Aurobindo Pharma USA and Lupin Pharmaceuticals. Broad incumbents are Hikma Pharmaceuticals and Endo International (Par Pharmaceutical).
Does Strides Pharma Inc. have an API?
No public API is recorded for Strides Pharma Inc..
What industry is Strides Pharma Inc. in?
Strides Pharma Inc.'s product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.